Trial Outcomes & Findings for Comparison of Different Ventilator and Vaporizer Technologies to Study Economic and Environmental Implications (NCT NCT04851314)

NCT ID: NCT04851314

Last Updated: 2021-08-10

Results Overview

The purpose of this study is to test whether or not the use of a low volume ventilator in an anesthesia machine reduces anesthetic costs significantly as compared to other high volume machines. The study will compare the FLOW-i anesthesia machine to a GE anesthesia machine during routine elective general surgery in patients with ASA ratings of 1-2 under general anesthesia receiving standard care.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

110 participants

Primary outcome timeframe

Intraoperative (minimum of 2 hours of anesthesia)

Results posted on

2021-08-10

Participant Flow

Some enrolled subjects were excluded due to unforeseen circumstances in the clinical workflow e.g. a change in anesthetic preference or canceled surgery. Data from these cases could not provide meaningful results for analysis.

Participant milestones

Participant milestones
Measure
Maquet Flow-i C20
Subjects receiving the Maquet Flow-i C20 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates
GE Aisys CS2
Subjects receiving the GE Aisys CS2 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates
Overall Study
STARTED
55
55
Overall Study
COMPLETED
52
51
Overall Study
NOT COMPLETED
3
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Maquet Flow-i C20
Subjects receiving the Maquet Flow-i C20 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates
GE Aisys CS2
Subjects receiving the GE Aisys CS2 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates
Overall Study
Unable to complete research set-up procedures
0
2
Overall Study
Change in Anesthesia Plan (patient no longer meets inclusion criteria)
3
2

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Maquet Flow-i C20
n=52 Participants
Subjects receiving the Maquet Flow-i C20 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates.
GE Aisys CS2
n=51 Participants
Subjects receiving the GE Aisys CS2 anesthetic delivery machine will undergo standardized anesthetic protocol to evaluate anesthetic consumption rates.
Total
n=103 Participants
Total of all reporting groups
Age, Continuous
42 years
STANDARD_DEVIATION 14 • n=52 Participants
44 years
STANDARD_DEVIATION 13 • n=51 Participants
43 years
STANDARD_DEVIATION 13 • n=103 Participants
Sex: Female, Male
Female
35 Participants
n=52 Participants
29 Participants
n=51 Participants
64 Participants
n=103 Participants
Sex: Female, Male
Male
17 Participants
n=52 Participants
22 Participants
n=51 Participants
39 Participants
n=103 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: Intraoperative (minimum of 2 hours of anesthesia)

Population: Completed patient population for each ventilator type

The purpose of this study is to test whether or not the use of a low volume ventilator in an anesthesia machine reduces anesthetic costs significantly as compared to other high volume machines. The study will compare the FLOW-i anesthesia machine to a GE anesthesia machine during routine elective general surgery in patients with ASA ratings of 1-2 under general anesthesia receiving standard care.

Outcome measures

Outcome measures
Measure
Maquet Flow-i C20
n=52 Participants
Maquet Flow-i C20 (ICU certified ventilator): Examine anesthetic consumption rates
GE Aisys CS2
n=51 Participants
GE Aisys CS2 (Non-ICU certified ventilator): Examine anesthetic consumption rates
Primary Study Variable: Amount of Gas Vaporized Anesthetic Per Minute Anesthesia
95.48 grams/minute
Standard Deviation 49.29
119.3 grams/minute
Standard Deviation 62.22

SECONDARY outcome

Timeframe: Up to 24 hours

Population: same as primary outcome measure

Time it took for patient to be safely discharged from the post-anesthesia care unit (PACU). The Aldrete Score evaluates recovery after anesthesia and patient readiness to be discharged from PACU. The patient is assessed for consciousness, mobility, breathing, circulation, and color. The evaluation occurs immediately after surgery and then every (1) hour before the patient is deemed ready for discharge.

Outcome measures

Outcome measures
Measure
Maquet Flow-i C20
n=52 Participants
Maquet Flow-i C20 (ICU certified ventilator): Examine anesthetic consumption rates
GE Aisys CS2
n=51 Participants
GE Aisys CS2 (Non-ICU certified ventilator): Examine anesthetic consumption rates
Time to Reach Aldrete > 8
98.13 minutes
Standard Deviation 51.83
89.18 minutes
Standard Deviation 52.09

SECONDARY outcome

Timeframe: Intraoperative (minimum of 2 hours of anesthesia)

Population: same as primary outcome

Time it took to remove patient from mechanical ventilation

Outcome measures

Outcome measures
Measure
Maquet Flow-i C20
n=52 Participants
Maquet Flow-i C20 (ICU certified ventilator): Examine anesthetic consumption rates
GE Aisys CS2
n=52 Participants
GE Aisys CS2 (Non-ICU certified ventilator): Examine anesthetic consumption rates
Time to Extubation From Weaning
10.37 minutes
Standard Deviation 6.321
10.78 minutes
Standard Deviation 6.413

Adverse Events

Maquet Flow-i C20

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

GE Aisys CS2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Robert Ryan Field

UC Irvine Health

Phone: 7145065703

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place